Skip to main content
. 2024 Mar 6;12:e47744. doi: 10.2196/47744

Table 2.

Baseline characteristics of patients with advanced head and neck cancer (HNC) included in 2 data sets under evaluationa.

Characteristic Data set A (n=7366) Data set B (n=11,386)
Sex, n (%)

Female 1723 (23.4) 3408 (29.9)

Male 5643 (76.6) 7967 (70)

Missing or unknown 0 (0) 11 (0.1)
Age at first advanced HNC diagnosis (y), median (IQR) 65 (58-72) 61 (54-68)
Age at first advanced HNC diagnosis (y), n (%)

<18 0 (0) 31 (0.27)

18-44 187 (2.53) 688 (6.04)

45-64 3402 (46.19) 5955 (52.3)

65-88 3777 (51.28) 4111 (36.11)

≥89 0 (0) 6 (0.05)

Missing or unknown 0 (0) 595 (5.23)
Race or ethnicity, n (%)

American Indian or Alaska Native N/Ab 40 (0.35)

Asian 103 (1.4) 165 (1.45)

Black or African American 487 (6.61) 1250 (10.98)

Hispanic or Latino 13 (0.18) 0 (0)

Native Hawaiian or other Pacific Islander N/A 6 (0.05)

White 4939 (67.05) 9239 (81.14)

Missing 650 (8.82) 686 (6.02)

Other race 1174 (15.94) 0 (0)
AJCCc stage at first HNC diagnosis, n (%)

0 2 (0.03) 28 (0.25)

I 419 (5.69) 603 (5.3)

II 505 (6.86) 542 (4.76)

III 929 (12.61) 798 (7.01)

IV 4330 (58.78) 4978 (43.72)

Missing or unknown 1181 (16.03) 4437 (38.97)
Year of first advanced HNC diagnosis, n (%)

Before 2006 0 (0) 1245 (10.9)

2006-2009 0 (0) 1537 (13.5)

2010-2012 1068 (14.5) 2721 (23.9)

2013-2018 5435 (73.8) 5577 (49.0)

2019 or later 863 (11.7) 306 (2.7)

aPercentages may not add up to 100% because of rounding.

bN/A: not applicable.

cAJCC: American Joint Committee on Cancer.